Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Easy to use and accessible to patients via their smart devices, IQVIA eCOA enables customers to build and deploy real-time patient data collection solutions in clinical research and real-world studies. The platform provides a superior user experience for study teams and patients.
The IQVIA eCOA library provides robust electronic instruments on-demand, giving sponsors instant access to validated tools that are needed in a given study. We currently have over 1,400 pre-configured assessments in the library and are continuing to build it out further.
Benefits of our library include:
IQVIA eCOA cuts up to three months from the industry standard eCOA development timeline. Our eCOA development timelines are between 4-6 weeks, compared to the industry standard of 12-16+ weeks.
By incorporating an agile development process, and with capabilities including our library of pre-built assessments, IQVIA eCOA dramatically reduces the time to develop these tools while improving data quality and enhancing the patient experience. Current industry timelines for most eCOA vendors is between 12-16 weeks. However, 16 weeks or longer is more common given the outdated technologies utilized and workflow processes that lead to issues and cause delays.
Source: ePRO Consortium: https://c-path.org/wp-content/uploads/2019/05/2019_session5_ecoa_final.pdf
A Clinical Outcome Assessment (COA) is a measure that describes or reflects how a patient feels, functions, or survives. Types of COAs include:
Source: https://www.fda.gov/about-fda/clinical-outcome-assessment-coa-frequently-asked-questions#COADefinition
An electronic Clinical Outcome Assessment (eCOA) is a method of capturing patient experience data electronically in clinical trials and real-world studies.
eCOA platforms intelligently automate capturing a patient's experiences through robust and reliable electronic measures, providing real-time insights that inform trial progress and demonstrate results.
The IQVIA electronic Clinical Outcome Assessment (eCOA) solution is an advanced study build and execution platform to help optimize real-time, direct-from-patient data collection. Fast, flexible and proven, IQVIA eCOA runs on devices patients already know and use to collect direct-from-patient data that is clean and ready to use in real time across clinical workflows. As an agile solution, IQVIA eCOA accelerates trials and enhances the patient experience so you can bring new medicines to market faster.
At the center of our eCOA solution is the Sculptor tool. Built on a highly secure, scalable SaaS platform, Sculptor enables simple set up of all eCOA study activities. The dynamic building tool makes it easy to create and deploy your own eCOA solution and view a functioning version of the design on multiple devices simultaneously. Key features include:
Scribe is the patient facing application as part of the IQVIA eCOA solution. For patients, the app features a simple and consistent, user-friendly design that encourages interaction. Key functionalities include:
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
In these short demo videos, learn more about some of the key capabilities within the IQVIA eCOA platform including how to easily create an assessment, utilize the AI design tool, access automated screenshots and documentation, export/import translations, and view study data and reports.
Get to know our partners